Diabetes, Obesity and Metabolism

AMP-activated protein kinase: role in metabolism and therapeutic implications
pp. 591-602(12)
Authors: Schimmack, Greg; DeFronzo, Ralph A.; Musi, Nicolas

Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome
pp. 603-610(8)
Authors: Correia, Marcelo L. G.; Rahmouni, Kamal

Novel insulin analogues and its mitogenic potential
pp. 611-620(10)
Authors: Zib, Ivana; Raskin, Philip

Catecholamine storage vesicles and the metabolic syndrome: the role of the chromogranin A fragment pancreastatin
pp. 621-633(13)
Authors: Zhang, Kuixing; Rao, Fangwen; Wen, Gen; Salem, Rany M.; Vaingankar, Sucheta; Mahata, Manjula; Mahapatra, Nitish R.; Lillie, Elizabeth O.; Cadman, Peter E.; Friese, Ryan S.; Hamilton, Bruce A.; Hook, Vivian Y.; Mahata, Sushil K.; Taupenot, Laurent; O'Connor, Daniel T.

Inhaled insulin delivery - where are we now?
pp. 634-642(9)
Authors: Muchmore, Douglas B.; Gates, Jeffrey R.

Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control
pp. 643-649(7)
Authors: Rosenstock,; Rood, J.; Cobitz,; Huang,; Garber,

Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
pp. 650-660(11)
Authors: Rosenstock,; Rood,; Cobitz,; Biswas,; Chou,; Garber,

Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells
pp. 661-668(8)
Authors: Hamel,; Fawcett,; Tsui,; Bennett,; Duckworth,

Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMI
pp. 669-673(5)
Authors: Biesenbach,; Raml,; Alsaraji,

Reduced left ventricular mass after treatment of obese patients with sibutramine: an echocardiographic multicentre study
pp. 674-681(8)
Authors: Wirth,; Scholze,; Sharma,; Matiba,; Boenner,

Multiple mealtime administration of biphasic insulin aspart 30 versus traditional basal-bolus human insulin treatment in patients with type 1 diabetes
pp. 682-689(8)
Authors: Chen,; Lauritzen,; Bojesen,; Christiansen,

The metabolic syndrome in type 2 diabetes: When does it matter?
pp. 690-697(8)
Authors: Wong,; Molyneaux,; Constantino,; Twigg,; Yue,

Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men
pp. 698-702(5)
Authors: Chan,; Watts,; Ng,; Hua,; Song,; Barrett,

Obesity risk associated with the K121Q polymorphism of the glycoprotein PC-1 gene
pp. 703-708(6)
Authors: Wan,; Zhang,; Wang,; Han,; Gong,; Jin,

Variant K of butyrylcholinesterase and risk of early-onset type 1 diabetes mellitus in Euro-Brazilians
pp. 709-711(3)

Re-feeding syndrome following adjustable gastric banding
pp. 712-713(2)

Hyperbaric exposure with high oxygen concentration inhibits growth-associated increase in the glucose level of diabetic Goto-Kakizaki rats
pp. 714-715(2)

News and Views
pp. 716-718(3)
Author: Holt, Richard I. G.

Acknowledgement to reviewers
pp. 719-720(2)